The higher AD prevalence previously reported in women [44] together with evidence of heightened female inflammatory responses [45] and relationship between tauopathy and menopause [46] could potentially explain why women are more vulnerable to tau deposition than men. The gene discussed is MAPT; the disease is tauopathy.